NEXI logo

NexImmune (NEXI) Company Overview

Profile

Full Name:

NexImmune, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

February 12, 2021

Indexes:

Not included

Description:

NexImmune, or NEXI, is a biotechnology company focused on developing innovative immunotherapies for cancer treatment. They use a unique technology to create personalized T cell therapies that aim to enhance the body’s immune response against tumors, offering new hope for patients with various types of cancer.

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Feb 6, 2025

Recent annual earnings:

Mar 9, 2023
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Oct 19, 2023

Analyst ratings

Recent major analysts updates

Nov 16, 22 Cantor Fitzgerald
Neutral
Nov 15, 22 Raymond James
Market Perform
Aug 16, 22 Raymond James
Outperform
Aug 16, 22 Barclays
Overweight
Jun 1, 22 BTIG
Buy
Apr 1, 22 Barclays
Overweight
Feb 22, 22 Raymond James
Outperform
Nov 15, 21 Raymond James
Outperform
Apr 1, 21 Raymond James
Outperform
Mar 9, 21 Cantor Fitzgerald
Overweight

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

NexImmune (NEXI) Stock Rockets 80% Ahead of Potential Liquidation
NexImmune (NEXI) Stock Rockets 80% Ahead of Potential Liquidation
NexImmune (NEXI) Stock Rockets 80% Ahead of Potential Liquidation
NEXI
InvestorPlaceJanuary 9, 2024

Shares of NexImmune (NASDAQ: NEXI ) stock are skyrocketing higher ahead of the company's special meeting of stockholders. The meeting was initially set for Dec. 21 with a record date of Nov. 6.

Dear NEXI Stock Fans, Mark Your Calendars for Jan. 18
Dear NEXI Stock Fans, Mark Your Calendars for Jan. 18
Dear NEXI Stock Fans, Mark Your Calendars for Jan. 18
NEXI
InvestorPlaceJanuary 3, 2024

Inexplicably, shares of embattled immunotherapy specialist NexImmune (NASDAQ: NEXI ) are skyrocketing more than 190% despite efforts to dissolve the business. An earlier attempt to vote on the liquidation and dissolution of the biotechnology enterprise failed due to a lack of quorum.

NEXI Stock Halted: What's Going on With NexImmune Shares Today?
NEXI Stock Halted: What's Going on With NexImmune Shares Today?
NEXI Stock Halted: What's Going on With NexImmune Shares Today?
NEXI
InvestorPlaceDecember 1, 2023

Following a dramatic spike in shares yesterday, exchange operators at Nasdaq pulled the circuit breaker on NexImmune (NASDAQ: NEXI ). Though seemingly offering innovative solutions to disease treatment, the biotechnology firm has lost almost all its value since its initial public offering in 2021.

Why Is NexImmune (NEXI) Stock Up 353% Today?
Why Is NexImmune (NEXI) Stock Up 353% Today?
Why Is NexImmune (NEXI) Stock Up 353% Today?
NEXI
InvestorPlaceDecember 1, 2023

NexImmune (NASDAQ: NEXI ) stock is heading higher on Friday despite a lack of news from the clinical-stage biotechnology company. There are no new press releases for filings with the Securities and Exchange Commission (SEC) that help explain why NEXI stock is up today.

FAQ

  • What is the ticker symbol for NexImmune?
  • Does NexImmune pay dividends?
  • What sector is NexImmune in?
  • What industry is NexImmune in?
  • What country is NexImmune based in?
  • When did NexImmune go public?
  • Is NexImmune in the S&P 500?
  • Is NexImmune in the NASDAQ 100?
  • Is NexImmune in the Dow Jones?
  • When was NexImmune's last earnings report?
  • When does NexImmune report earnings?
  • Should I buy NexImmune stock now?

What is the ticker symbol for NexImmune?

The ticker symbol for NexImmune is NASDAQ:NEXI

Does NexImmune pay dividends?

No, NexImmune does not pay dividends

What sector is NexImmune in?

NexImmune is in the Healthcare sector

What industry is NexImmune in?

NexImmune is in the Biotechnology industry

What country is NexImmune based in?

NexImmune is headquartered in United States

When did NexImmune go public?

NexImmune's initial public offering (IPO) was on February 12, 2021

Is NexImmune in the S&P 500?

No, NexImmune is not included in the S&P 500 index

Is NexImmune in the NASDAQ 100?

No, NexImmune is not included in the NASDAQ 100 index

Is NexImmune in the Dow Jones?

No, NexImmune is not included in the Dow Jones index

When was NexImmune's last earnings report?

NexImmune's most recent earnings report was on Feb 6, 2025

When does NexImmune report earnings?

The date for NexImmune's next earnings report has not been announced yet

Should I buy NexImmune stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions